Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
about
Remodeling of glucose metabolism precedes pressure overload-induced left ventricular hypertrophy: review of a hypothesis.The two faces of miR-29Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart.Quantitative PET imaging detects early metabolic remodeling in a mouse model of pressure-overload left ventricular hypertrophy in vivoDeficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycinInterrogating functional integration between injected pluripotent stem cell-derived cells and surrogate cardiac tissue.Mouse cardiac acyl coenzyme a synthetase 1 deficiency impairs Fatty Acid oxidation and induces cardiac hypertrophy.Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy.Mitochondrial dysfunction in some triple-negative breast cancer cell lines: role of mTOR pathway and therapeutic potentialGlucose-6-phosphate isomerase deficiency results in mTOR activation, failed translocation of lipin 1α to the nucleus and hypersensitivity to glucose: Implications for the inherited glycolytic diseaseLoss of long-chain acyl-CoA synthetase isoform 1 impairs cardiac autophagy and mitochondrial structure through mechanistic target of rapamycin complex 1 activation.Cardiomyocyte-specific deletion of leptin receptors causes lethal heart failure in Cre-recombinase-mediated cardiotoxicity.Nonischemic heart failure in diabetes mellitus.Nutrient-sensing mTORC1: Integration of metabolic and autophagic signalsInsulin signalling in the heart.Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFκB-Opa-1 signaling pathwayCardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes.Amino acids and derivatives, a new treatment of chronic heart failure?Rethinking cardiac metabolism: metabolic cycles to refuel and rebuild the failing heart.Fuel availability and fate in cardiac metabolism: A tale of two substrates.Metabolism in cardiomyopathy: every substrate matters.Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.The combination of the novel glycolysis inhibitor 3-BrOP and rapamycin is effective against neuroblastomaCardiac energy dependence on glucose increases metabolites related to glutathione and activates metabolic genes controlled by mechanistic target of rapamycin.Insulin resistance: marker or mediator?SH003 suppresses breast cancer growth by accumulating p62 in autolysosomes.Cardiac Metabolism in Perspective.Functionally redundant control of cardiac hypertrophic signaling by inositol 1,4,5-trisphosphate receptors.Exercise training reduces insulin resistance and upregulates the mTOR/p70S6k pathway in cardiac muscle of diet-induced obesity rats.
P2860
Q26853332-C8148A76-7C7E-46B0-99FA-3E1032EFA996Q26996481-871F9C3B-F953-47B6-A579-50842B3BF451Q30417331-C52F1B5E-3BEB-450E-A169-E2CAB2838100Q30418046-477C10B2-FA40-4890-B473-C7ECEBA81258Q33719493-549746DC-CA04-429C-9C25-5C33EB925B4BQ33734315-5466A4A6-5F25-4778-BB8B-88F85E926992Q34742779-5EC26D0D-BCD1-410B-88C7-68AE5BB27EC8Q34924245-627D7183-1B66-4B39-ABC6-F0509FE5B4F2Q35000248-12365CE5-12FA-4860-B713-5E7EA9DB6BA7Q35257078-9F6E3EEE-9223-4339-BFB0-1559162F2A81Q36171264-479D35C7-5CDD-4BF1-AB97-167E6E60D112Q36494881-0AE1E2E5-723E-4D32-A458-24062C456213Q36762969-944A50AE-BEBD-4926-A4AD-067C584A1DCEQ37008888-C6E08438-5524-4B7F-B545-C936A55FFA60Q37129268-864EE9CC-E1CE-47BC-8C02-ED6C60C6891BQ37403315-7AD99AE1-C130-46F9-AF22-4A44927C8349Q38129182-96277BF1-A30C-4FB2-A7F2-32BBC8E220BFQ38219915-1F7297DA-6C78-4488-B136-87C25E53F9E6Q38265521-5127F20F-4586-4E89-B50B-FC235325AA1FQ38781072-93F83ADE-8DBF-4822-904C-3408D0067682Q39232032-827BE1B4-817C-4E4C-BB23-8B733B4E4CDCQ39247355-71C6BD59-E561-42A6-B0BC-C4BE6F295EC7Q39648449-3CDA6C02-A65B-41E7-A9FC-10DE0F25C7E3Q41824788-EE32D1D3-CBF9-4202-B962-89AC8235D0CAQ42870472-4E1F8D61-A921-4B9E-8541-C8F449B24EEBQ45737026-6E0F25DF-39D3-44D2-881F-26633C3FCDCCQ47633793-031596D4-DA7A-4340-B91B-0818A792B229Q47783365-558DE541-5E9B-492F-8D7A-A762ED94DAF1Q51393004-969A819B-F665-4924-99E4-10B7D6377DCF
P2860
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
@ast
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
@en
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
@nl
type
label
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
@ast
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
@en
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
@nl
prefLabel
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
@ast
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
@en
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
@nl
P2093
P2860
P921
P1476
Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.
@en
P2093
Heinrich Taegtmeyer
Patrick H Guthrie
Saumya Sharma
Suzanne S Chan
P2860
P356
10.1016/J.CARDIORES.2007.05.004
P577
2007-05-10T00:00:00Z